Neurodegenerative Diseases Market Report

Europe Neurodegenerative Diseases Market Size, Status and Forecast 2014-2026

  • POSTDATE：Oct 22, 2019
  • PAGES：160
  • REPORT CODE：GMM341743
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The Neurodegenerative Diseases market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 10.3% during the forecast period. Focusing on the Europe market, this report analyzes the specific consumption structure, such as types and end users. In order to present the status of the circulation of this product in different Europe countries, this report covers top export and import countries to confirm the potential markets. Leading countries such as Germany, UK, France, Italy, Spain, Poland, Russia, Switzerland, Turkey, Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden), Benelux (Belgium, Netherlands, and Luxembourg), Baltic States (Estonia, Latvia, and Lithuania) and other countries, the market status and consumption potential of these countries are covered in the research, providing valuable opinions of strategic adjustments for existing groups and new entrants.

    The Snapshot of Europe Neurodegenerative Diseases Market Segmentations:

    By Player:

    • Biogen Idec

    • F. Hoffmann-La Roche

    • Abbvie

    • Eisai

    • Astellas

    • Eli Lilly

    • Boehringer Ingelheim

    • Actavis

    • Covis

    • Desitin Arzneimittel

    • Endo International

    • Bayer

    • Active Biotech

    • UCB

    • F Hoffmann-La Roche

    • Novartis

    • Archer Pharmaceuticals

    • Akorn

    • Acorda Therapeutics

    • AB Science

    • Merck Serono

    • Adamas Pharmaceuticals

    • Pfizer

    • Teva Pharmaceutical Industries

    By Type:

    • Type 1

    • Type 2

    • Type 3

    By End-User:

    • End-User 1

    • End-User 2

    • End-User 3

    By Region:

    • Germany

    • UK

    • France

    • Italy

    • Spain

    • Poland

    • Russia

    • Switzerland

    • Turkey

    • Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden)

      • Denmark

      • Finland

      • Norway

      • Sweden

      • Iceland

    • Benelux (Belgium, Netherlands, and Luxembourg)

      • Belgium

      • Netherlands

      • Luxembourg

    • Baltic States (Estonia, Latvia, and Lithuania)

      • Estonia

      • Latvia

      • Lithuania

  • Table of Contents

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Neurodegenerative Diseases Market

    • 1.3 Market Segment by Type

    • 1.3.1 Europe Neurodegenerative Diseases Market Size and Growth Rate of Type 1 from 2014 to 2026

    • 1.3.2 Europe Neurodegenerative Diseases Market Size and Growth Rate of Type 2 from 2014 to 2026

    • 1.3.3 Europe Neurodegenerative Diseases Market Size and Growth Rate of Type 3 from 2014 to 2026

    • 1.4 Market Segment by Application

    • 1.4.1 Europe Neurodegenerative Diseases Market Size and Growth Rate of End-User 1 from 2014 to 2026

    • 1.4.2 Europe Neurodegenerative Diseases Market Size and Growth Rate of End-User 2 from 2014 to 2026

    • 1.4.3 Europe Neurodegenerative Diseases Market Size and Growth Rate of End-User 3 from 2014 to 2026

    • 1.5 Market Segment by Regions

      • 1.5.1 Germany Neurodegenerative Diseases Market Size and Growth Rate from 2014 to 2026

      • 1.5.2 UK Neurodegenerative Diseases Market Size and Growth Rate from 2014 to 2026

      • 1.5.3 France Neurodegenerative Diseases Market Size and Growth Rate from 2014 to 2026

      • 1.5.4 Italy Neurodegenerative Diseases Market Size and Growth Rate from 2014 to 2026

      • 1.5.5 Spain Neurodegenerative Diseases Market Size and Growth Rate from 2014 to 2026

      • 1.5.6 Poland Neurodegenerative Diseases Market Size and Growth Rate from 2014 to 2026

      • 1.5.7 Russia Neurodegenerative Diseases Market Size and Growth Rate from 2014 to 2026

      • 1.5.8 Switzerland Neurodegenerative Diseases Market Size and Growth Rate from 2014 to 2026

      • 1.5.9 Turkey Neurodegenerative Diseases Market Size and Growth Rate from 2014 to 2026

      • 1.5.10 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Neurodegenerative Diseases Market Size and Growth Rate from 2014 to 2026

      • 1.5.11 Benelux (Belgium, Netherlands, and Luxembourg) Neurodegenerative Diseases Market Size and Growth Rate from 2014 to 2026

      • 1.5.12 Baltic States (Estonia, Latvia, and Lithuania) Neurodegenerative Diseases Market Size and Growth Rate from 2014 to 2026

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    3 Segmentation of Neurodegenerative Diseases Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Commercial Products Types of Major Venders

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Neurodegenerative Diseases by Major Types

      • 3.4.1 Market Size and Growth Rate of Type 1

      • 3.4.2 Market Size and Growth Rate of Type 2

      • 3.4.3 Market Size and Growth Rate of Type 3

    4 Segmentation of Neurodegenerative Diseases Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Neurodegenerative Diseases by Major End-Users

      • 4.4.1 Market Size and Growth Rate of Neurodegenerative Diseases for End-User 1

      • 4.4.2 Market Size and Growth Rate of Neurodegenerative Diseases for End-User 2

      • 4.4.3 Market Size and Growth Rate of Neurodegenerative Diseases for End-User 3

    5 Market Analysis by Major Regions

    • 5.1 Europe Neurodegenerative Diseases Production Analysis by Top Regions

    • 5.2 Europe Neurodegenerative Diseases Consumption Analysis by Top Regions

    • 5.3 Europe Neurodegenerative Diseases Production, Import, Consumption and Export Analysis by Regions

      • 5.3.1 Germany Neurodegenerative Diseases Production, Import, Consumption and Export Analysis

      • 5.3.2 UK Neurodegenerative Diseases Production, Import, Consumption and Export Analysis

      • 5.3.3 France Neurodegenerative Diseases Production, Import, Consumption and Export Analysis

      • 5.3.4 Italy Neurodegenerative Diseases Production, Import, Consumption and Export Analysis

      • 5.3.5 Spain Neurodegenerative Diseases Production, Import, Consumption and Export Analysis

      • 5.3.6 Poland Neurodegenerative Diseases Production, Import, Consumption and Export Analysis

      • 5.3.7 Russia Neurodegenerative Diseases Production, Import, Consumption and Export Analysis

      • 5.3.8 Switzerland Neurodegenerative Diseases Production, Import, Consumption and Export Analysis

      • 5.3.9 Turkey Neurodegenerative Diseases Production, Import, Consumption and Export Analysis

      • 5.3.10 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Neurodegenerative Diseases Production, Import, Consumption and Export Analysis

      • 5.3.11 Benelux (Belgium, Netherlands, and Luxembourg) Neurodegenerative Diseases Production, Import, Consumption and Export Analysis

      • 5.3.12 Baltic States (Estonia, Latvia, and Lithuania) Neurodegenerative Diseases Production, Import, Consumption and Export Analysis

    6 Product Circulation of Neurodegenerative Diseases Market among Top Countries

    • 6.1 Top 5 Export Countries in Neurodegenerative Diseases Market from 2014 to 2019

      • 6.1.1 Top 5 Export Countries’ Export Value Analysis in Neurodegenerative Diseases Market from 2014 to 2019

      • 6.1.2 Top 5 Export Countries’ Export Volume Analysis in Neurodegenerative Diseases Market from 2014 to 2019

    • 6.2 Top 5 Import Countries in Neurodegenerative Diseases Market from 2014 to 2019

      • 6.2.1 Top 5 Import Countries’ Import Value Analysis in Neurodegenerative Diseases Market from 2014 to 2019

      • 6.2.2 Top 5 Import Countries’ Import Volume Analysis in Neurodegenerative Diseases Market from 2014 to 2019

    • 6.3 Emerging Top 3 Export Countries Analysis

    • 6.4 Emerging Top 3 Import Countries Analysis

    7. Germany Neurodegenerative Diseases Landscape Analysis

    • 7.1 Germany Neurodegenerative Diseases Landscape Analysis by Major Types

    • 7.2 Germany Neurodegenerative Diseases Landscape Analysis by Major End-Users

    8. UK Neurodegenerative Diseases Landscape Analysis

    • 8.1 UK Neurodegenerative Diseases Landscape Analysis by Major Types

    • 8.2 UK Neurodegenerative Diseases Landscape Analysis by Major End-Users

    9. France Neurodegenerative Diseases Landscape Analysis

    • 9.1 France Neurodegenerative Diseases Landscape Analysis by Major Types

    • 9.2 France Neurodegenerative Diseases Landscape Analysis by Major End-Users

    10. Italy Neurodegenerative Diseases Landscape Analysis

    • 10.1 Italy Neurodegenerative Diseases Landscape Analysis by Major Types

    • 10.2 Italy Neurodegenerative Diseases Landscape Analysis by Major End-Users

    11. Spain Neurodegenerative Diseases Landscape Analysis

    • 11.1 Spain Neurodegenerative Diseases Landscape Analysis by Major Types

    • 11.2 Spain Neurodegenerative Diseases Landscape Analysis by Major End-Users

    12. Poland Neurodegenerative Diseases Landscape Analysis

    • 12.1 Poland Neurodegenerative Diseases Landscape Analysis by Major Types

    • 12.2 Poland Neurodegenerative Diseases Landscape Analysis by Major End-Users

    13. Russia Neurodegenerative Diseases Landscape Analysis

    • 13.1 Russia Neurodegenerative Diseases Landscape Analysis by Major Types

    • 13.2 Russia Neurodegenerative Diseases Landscape Analysis by Major End-Users

    14. Switzerland Neurodegenerative Diseases Landscape Analysis

    • 14.1 Switzerland Neurodegenerative Diseases Landscape Analysis by Major Types

    • 14.2 Switzerland Neurodegenerative Diseases Landscape Analysis by Major End-Users

    15. Turkey Neurodegenerative Diseases Landscape Analysis

    • 15.1 Turkey Neurodegenerative Diseases Landscape Analysis by Major Types

    • 15.2 Turkey Neurodegenerative Diseases Landscape Analysis by Major End-Users

    16. Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Neurodegenerative Diseases Landscape Analysis

    • 16.1 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Neurodegenerative Diseases Landscape Analysis by Major Types

    • 16.2 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Neurodegenerative Diseases Landscape Analysis by Major End-Users

    • 16.3 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Neurodegenerative Diseases Landscape Analysis by Top Countries

      • 16.3.1 Denmark Neurodegenerative Diseases Market Volume and Growth Rate

      • 16.3.2 Finland Neurodegenerative Diseases Market Volume and Growth Rate

      • 16.3.3 Norway Neurodegenerative Diseases Market Volume and Growth Rate

      • 16.3.4 Sweden Neurodegenerative Diseases Market Volume and Growth Rate

      • 16.3.6 Iceland Neurodegenerative Diseases Market Volume and Growth Rate

    17 Benelux (Belgium, Netherlands, and Luxembourg) Neurodegenerative Diseases Landscape Analysis

    • 17.1 Benelux (Belgium, Netherlands, and Luxembourg) Neurodegenerative Diseases Landscape Analysis by Major Types

    • 17.2 Benelux (Belgium, Netherlands, and Luxembourg) Neurodegenerative Diseases Landscape Analysis by Major End-Users

    • 17.3 Benelux (Belgium, Netherlands, and Luxembourg) Neurodegenerative Diseases Landscape Analysis by Top Countries

      • 17.3.1 Belgium Neurodegenerative Diseases Market Volume and Growth Rate

      • 17.3.2 Netherlands Neurodegenerative Diseases Market Volume and Growth Rate

      • 17.3.3 Luxembourg Neurodegenerative Diseases Market Volume and Growth Rate

    18 Baltic States (Estonia, Latvia, and Lithuania) Neurodegenerative Diseases Landscape Analysis

    • 18.1 Baltic States (Estonia, Latvia, and Lithuania) Neurodegenerative Diseases Landscape Analysis by Major Types

    • 18.2 Baltic States (Estonia, Latvia, and Lithuania) Neurodegenerative Diseases Landscape Analysis by Major End-Users

    • 18.3 Baltic States (Estonia, Latvia, and Lithuania) Neurodegenerative Diseases Landscape Analysis by Top Countries

      • 18.3.1 Estonia Neurodegenerative Diseases Market Volume and Growth Rate

      • 18.3.2 Latvia Neurodegenerative Diseases Market Volume and Growth Rate

      • 18.3.3 Lithuania Neurodegenerative Diseases Market Volume and Growth Rate

    19 Major Players Profiles

    • 19.1 Biogen Idec

      • 19.1.1 Biogen Idec Company Profile and Development Status

      • 19.1.2 Market Performance

      • 19.1.3 Product and Service Introduction

    • 19.2 F. Hoffmann-La Roche

      • 19.2.1 F. Hoffmann-La Roche Company Profile and Development Status

      • 19.2.2 Market Performance

      • 19.2.3 Product and Service Introduction

    • 19.3 Abbvie

      • 19.3.1 Abbvie Company Profile and Development Status

      • 19.3.2 Market Performance

      • 19.3.3 Product and Service Introduction

    • 19.4 Eisai

      • 19.4.1 Eisai Company Profile and Development Status

      • 19.4.2 Market Performance

      • 19.4.3 Product and Service Introduction

    • 19.5 Astellas

      • 19.5.1 Astellas Company Profile and Development Status

      • 19.5.2 Market Performance

      • 19.5.3 Product and Service Introduction

    • 19.6 Eli Lilly

      • 19.6.1 Eli Lilly Company Profile and Development Status

      • 19.6.2 Market Performance

      • 19.6.3 Product and Service Introduction

    • 19.7 Boehringer Ingelheim

      • 19.7.1 Boehringer Ingelheim Company Profile and Development Status

      • 19.7.2 Market Performance

      • 19.7.3 Product and Service Introduction

    • 19.8 Actavis

      • 19.8.1 Actavis Company Profile and Development Status

      • 19.8.2 Market Performance

      • 19.8.3 Product and Service Introduction

    • 19.9 Covis

      • 19.9.1 Covis Company Profile and Development Status

      • 19.9.2 Market Performance

      • 19.9.3 Product and Service Introduction

    • 19.10 Desitin Arzneimittel

      • 19.10.1 Desitin Arzneimittel Company Profile and Development Status

      • 19.10.2 Market Performance

      • 19.10.3 Product and Service Introduction

    • 19.11 Endo International

      • 19.11.1 Endo International Company Profile and Development Status

      • 19.11.2 Market Performance

      • 19.11.3 Product and Service Introduction

    • 19.12 Bayer

      • 19.12.1 Bayer Company Profile and Development Status

      • 19.12.2 Market Performance

      • 19.12.3 Product and Service Introduction

    • 19.13 Active Biotech

      • 19.13.1 Active Biotech Company Profile and Development Status

      • 19.13.2 Market Performance

      • 19.13.3 Product and Service Introduction

    • 19.14 UCB

      • 19.14.1 UCB Company Profile and Development Status

      • 19.14.2 Market Performance

      • 19.14.3 Product and Service Introduction

    • 19.15 F Hoffmann-La Roche

      • 19.15.1 F Hoffmann-La Roche Company Profile and Development Status

      • 19.15.2 Market Performance

      • 19.15.3 Product and Service Introduction

    • 19.16 Novartis

      • 19.16.1 Novartis Company Profile and Development Status

      • 19.16.2 Market Performance

      • 19.16.3 Product and Service Introduction

    • 19.17 Archer Pharmaceuticals

      • 19.17.1 Archer Pharmaceuticals Company Profile and Development Status

      • 19.17.2 Market Performance

      • 19.17.3 Product and Service Introduction

    • 19.18 Akorn

      • 19.18.1 Akorn Company Profile and Development Status

      • 19.18.2 Market Performance

      • 19.18.3 Product and Service Introduction

    • 19.19 Acorda Therapeutics

      • 19.19.1 Acorda Therapeutics Company Profile and Development Status

      • 19.19.2 Market Performance

      • 19.19.3 Product and Service Introduction

    • 19.20 AB Science

      • 19.20.1 AB Science Company Profile and Development Status

      • 19.20.2 Market Performance

      • 19.20.3 Product and Service Introduction

    • 19.21 Merck Serono

      • 19.21.1 Merck Serono Company Profile and Development Status

      • 19.21.2 Market Performance

      • 19.21.3 Product and Service Introduction

    • 19.22 Adamas Pharmaceuticals

      • 19.22.1 Adamas Pharmaceuticals Company Profile and Development Status

      • 19.22.2 Market Performance

      • 19.22.3 Product and Service Introduction

    • 19.23 Pfizer

      • 19.23.1 Pfizer Company Profile and Development Status

      • 19.23.2 Market Performance

      • 19.23.3 Product and Service Introduction

    • 19.24 Teva Pharmaceutical Industries

      • 19.24.1 Teva Pharmaceutical Industries Company Profile and Development Status

      • 19.24.2 Market Performance

      • 19.24.3 Product and Service Introduction

    The List of Tables and Figures (Totals 69 Figures and 146 Tables)

    • Figure Product Picture

    • Figure Europe Neurodegenerative Diseases Market Size and Growth Rate of Type 1 from 2014 to 2026

    • Figure Europe Neurodegenerative Diseases Market Size and Growth Rate of Type 2 from 2014 to 2026

    • Figure Europe Neurodegenerative Diseases Market Size and Growth Rate of Type 3 from 2014 to 2026

    • Figure Europe Neurodegenerative Diseases Market Size and Growth Rate of End-User 1 from 2014 to 2026

    • Figure Europe Neurodegenerative Diseases Market Size and Growth Rate of End-User 2 from 2014 to 2026

    • Figure Europe Neurodegenerative Diseases Market Size and Growth Rate of End-User 3 from 2014 to 2026

    • Figure Germany Neurodegenerative Diseases Market Size and Growth Rate from 2014 to 2026

    • Figure UK Neurodegenerative Diseases Market Size and Growth Rate from 2014 to 2026

    • Figure France Neurodegenerative Diseases Market Size and Growth Rate from 2014 to 2026

    • Figure Italy Neurodegenerative Diseases Market Size and Growth Rate from 2014 to 2026

    • Figure Spain Neurodegenerative Diseases Market Size and Growth Rate from 2014 to 2026

    • Figure Poland Neurodegenerative Diseases Market Size and Growth Rate from 2014 to 2026

    • Figure Russia Neurodegenerative Diseases Market Size and Growth Rate from 2014 to 2026

    • Figure Switzerland Neurodegenerative Diseases Market Size and Growth Rate from 2014 to 2026

    • Figure Turkey Neurodegenerative Diseases Market Size and Growth Rate from 2014 to 2026

    • Figure Canada Neurodegenerative Diseases Market Size and Growth Rate from 2014 to 2026

    • Figure Mexico Neurodegenerative Diseases Market Size and Growth Rate from 2014 to 2026

    • Figure Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Neurodegenerative Diseases Market Size and Growth Rate from 2014 to 2026

    • Figure Denmark Neurodegenerative Diseases Market Size and Growth Rate from 2014 to 2026

    • Figure Finland Neurodegenerative Diseases Market Size and Growth Rate from 2014 to 2026

    • Figure Norway Neurodegenerative Diseases Market Size and Growth Rate from 2014 to 2026

    • Figure Sweden Neurodegenerative Diseases Market Size and Growth Rate from 2014 to 2026

    • Figure Iceland Neurodegenerative Diseases Market Size and Growth Rate from 2014 to 2026

    • Figure Benelux (Belgium, Netherlands, and Luxembourg) Neurodegenerative Diseases Market Size and Growth Rate from 2014 to 2026

    • Figure Belgium Neurodegenerative Diseases Market Size and Growth Rate from 2014 to 2026

    • Figure Netherlands Neurodegenerative Diseases Market Size and Growth Rate from 2014 to 2026

    • Figure Luxembourg Neurodegenerative Diseases Market Size and Growth Rate from 2014 to 2026

    • Figure Baltic States (Estonia, Latvia, and Lithuania) Neurodegenerative Diseases Market Size and Growth Rate from 2014 to 2026

    • Figure Estonia Neurodegenerative Diseases Market Size and Growth Rate from 2014 to 2026

    • Figure Latvia Neurodegenerative Diseases Market Size and Growth Rate from 2014 to 2026

    • Figure Lithuania Neurodegenerative Diseases Market Size and Growth Rate from 2014 to 2026

    • Figure Development Trends and Industry Dynamics of Neurodegenerative Diseases Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 6 Players from 2014 to 2019

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Table Specifications of Different Types of Neurodegenerative Diseases

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Neurodegenerative Diseases by Different Types from 2014 to 2026

    • Table Consumption Share of Neurodegenerative Diseases by Different Types from 2014 to 2026

    • Figure Market Size and Growth Rate of Type 1

    • Figure Market Size and Growth Rate of Type 2

    • Figure Market Size and Growth Rate of Type 3

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Table Consumption of Neurodegenerative Diseases by Different End-Users from 2014 to 2026

    • Table Consumption Share of Neurodegenerative Diseases by Different End-Users from 2014 to 2026

    • Figure Market Size and Growth Rate of End-User 1

    • Figure Market Size and Growth Rate of End-User 2

    • Figure Market Size and Growth Rate of End-User 3

    • Table Europe Neurodegenerative Diseases Production by Major Regions

    • Table Europe Neurodegenerative Diseases Production Share by Major Regions

    • Figure Europe Neurodegenerative Diseases Production Share by Major Countries and Regions in 2014

    • Table Europe Neurodegenerative Diseases Consumption by Major Regions

    • Table Europe Neurodegenerative Diseases Consumption Share by Major Regions

    • Table Germany Neurodegenerative Diseases Production, Import, Consumption and Export Analysis

    • Table UK Neurodegenerative Diseases Production, Import, Consumption and Export Analysis

    • Table France Neurodegenerative Diseases Production, Import, Consumption and Export Analysis

    • Table Italy Neurodegenerative Diseases Production, Import, Consumption and Export Analysis

    • Table Spain Neurodegenerative Diseases Production, Import, Consumption and Export Analysis

    • Table Poland Neurodegenerative Diseases Production, Import, Consumption and Export Analysis

    • Table Russia Neurodegenerative Diseases Production, Import, Consumption and Export Analysis

    • Table Switzerland Neurodegenerative Diseases Production, Import, Consumption and Export Analysis

    • Table Turkey Neurodegenerative Diseases Production, Import, Consumption and Export Analysis

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Neurodegenerative Diseases Production, Import, Consumption and Export Analysis

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Neurodegenerative Diseases Production, Import, Consumption and Export Analysis

    • Table Baltic States (Estonia, Latvia, and Lithuania) Neurodegenerative Diseases Production, Import, Consumption and Export Analysis

    • Table Top 5 Export Countries' Export Value Analysis in Neurodegenerative Diseases Market from 2014 to 2019

    • Table Top 5 Export Countries' Export Volume Analysis in Neurodegenerative Diseases Market from 2014 to 2019

    • Table Top 5 Import Countries' Import Value Analysis in Neurodegenerative Diseases Market from 2014 to 2019

    • Table Top 5 Import Countries' Import Volume Analysis in Neurodegenerative Diseases Market from 2014 to 2019

    • Figure Emerging Top 3 Export Countries Analysis

    • Figure Emerging Top 3 Import Countries Analysis

    • Table Germany Neurodegenerative Diseases Consumption by Types from 2014 to 2026

    • Table Germany Neurodegenerative Diseases Consumption Share by Types from 2014 to 2026

    • Table Germany Neurodegenerative Diseases Consumption by End-Users from 2014 to 2026

    • Table Germany Neurodegenerative Diseases Consumption Share by End-Users from 2014 to 2026

    • Table UK Neurodegenerative Diseases Consumption by Types from 2014 to 2026

    • Table UK Neurodegenerative Diseases Consumption Share by Types from 2014 to 2026

    • Table UK Neurodegenerative Diseases Consumption by End-Users from 2014 to 2026

    • Table UK Neurodegenerative Diseases Consumption Share by End-Users from 2014 to 2026

    • Table France Neurodegenerative Diseases Consumption by Types from 2014 to 2026

    • Table France Neurodegenerative Diseases Consumption Share by Types from 2014 to 2026

    • Table France Neurodegenerative Diseases Consumption by End-Users from 2014 to 2026

    • Table France Neurodegenerative Diseases Consumption Share by End-Users from 2014 to 2026

    • Table Italy Neurodegenerative Diseases Consumption by Types from 2014 to 2026

    • Table Italy Neurodegenerative Diseases Consumption Share by Types from 2014 to 2026

    • Table Italy Neurodegenerative Diseases Consumption by End-Users from 2014 to 2026

    • Table Italy Neurodegenerative Diseases Consumption Share by End-Users from 2014 to 2026

    • Table Spain Neurodegenerative Diseases Consumption by Types from 2014 to 2026

    • Table Spain Neurodegenerative Diseases Consumption Share by Types from 2014 to 2026

    • Table Spain Neurodegenerative Diseases Consumption by End-Users from 2014 to 2026

    • Table Spain Neurodegenerative Diseases Consumption Share by End-Users from 2014 to 2026

    • Table Poland Neurodegenerative Diseases Consumption by Types from 2014 to 2026

    • Table Poland Neurodegenerative Diseases Consumption Share by Types from 2014 to 2026

    • Table Poland Neurodegenerative Diseases Consumption by End-Users from 2014 to 2026

    • Table Poland Neurodegenerative Diseases Consumption Share by End-Users from 2014 to 2026

    • Table Russia Neurodegenerative Diseases Consumption by Types from 2014 to 2026

    • Table Russia Neurodegenerative Diseases Consumption Share by Types from 2014 to 2026

    • Table Russia Neurodegenerative Diseases Consumption by End-Users from 2014 to 2026

    • Table Russia Neurodegenerative Diseases Consumption Share by End-Users from 2014 to 2026

    • Table Switzerland Neurodegenerative Diseases Consumption by Types from 2014 to 2026

    • Table Switzerland Neurodegenerative Diseases Consumption Share by Types from 2014 to 2026

    • Table Switzerland Neurodegenerative Diseases Consumption by End-Users from 2014 to 2026

    • Table Switzerland Neurodegenerative Diseases Consumption Share by End-Users from 2014 to 2026

    • Table Turkey Neurodegenerative Diseases Consumption by Types from 2014 to 2026

    • Table Turkey Neurodegenerative Diseases Consumption Share by Types from 2014 to 2026

    • Table Turkey Neurodegenerative Diseases Consumption by End-Users from 2014 to 2026

    • Table Turkey Neurodegenerative Diseases Consumption Share by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Neurodegenerative Diseases Consumption by Types from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Neurodegenerative Diseases Consumption Share by Types from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Neurodegenerative Diseases Consumption by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Neurodegenerative Diseases Consumption Share by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Neurodegenerative Diseases Consumption by Major Countries from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Neurodegenerative Diseases Consumption Share by Major Countries from 2014 to 2026

    • Figure Denmark Neurodegenerative Diseases Market Volume and Growth Rate from 2014 to 2026

    • Figure Finland Neurodegenerative Diseases Market Volume and Growth Rate from 2014 to 2026

    • Figure Norway Neurodegenerative Diseases Market Volume and Growth Rate from 2014 to 2026

    • Figure Sweden Neurodegenerative Diseases Market Volume and Growth Rate from 2014 to 2026

    • Figure Iceland Neurodegenerative Diseases Market Volume and Growth Rate from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Neurodegenerative Diseases Consumption by Types from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Neurodegenerative Diseases Consumption Share by Types from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Neurodegenerative Diseases Consumption by End-Users from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Neurodegenerative Diseases Consumption Share by End-Users from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Neurodegenerative Diseases Consumption by Major Countries from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Neurodegenerative Diseases Consumption Share by Major Countries from 2014 to 2026

    • Figure Belgium Neurodegenerative Diseases Market Volume and Growth Rate from 2014 to 2026

    • Figure Netherlands Neurodegenerative Diseases Market Volume and Growth Rate from 2014 to 2026

    • Figure Luxembourg Neurodegenerative Diseases Market Volume and Growth Rate from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Neurodegenerative Diseases Consumption by Types from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Neurodegenerative Diseases Consumption Share by Types from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Neurodegenerative Diseases Consumption by End-Users from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Neurodegenerative Diseases Consumption Share by End-Users from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Neurodegenerative Diseases Consumption by Major Countries from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Neurodegenerative Diseases Consumption Share by Major Countries from 2014 to 2026

    • Figure Estonia Neurodegenerative Diseases Market Volume and Growth Rate from 2014 to 2026

    • Figure Latvia Neurodegenerative Diseases Market Volume and Growth Rate from 2014 to 2026

    • Figure Lithuania Countries Neurodegenerative Diseases Market Volume and Growth Rate from 2014 to 2026

    • Table Company Profile and Development Status of Biogen Idec

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Biogen Idec

    • Figure Sales and Growth Rate Analysis of Biogen Idec

    • Figure Revenue and Market Share Analysis of Biogen Idec

    • Table Product and Service Introduction of Biogen Idec

    • Table Company Profile and Development Status of F. Hoffmann-La Roche

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of F. Hoffmann-La Roche

    • Figure Sales and Growth Rate Analysis of F. Hoffmann-La Roche

    • Figure Revenue and Market Share Analysis of F. Hoffmann-La Roche

    • Table Product and Service Introduction of F. Hoffmann-La Roche

    • Table Company Profile and Development Status of Abbvie

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Abbvie

    • Figure Sales and Growth Rate Analysis of Abbvie

    • Figure Revenue and Market Share Analysis of Abbvie

    • Table Product and Service Introduction of Abbvie

    • Table Company Profile and Development Status of Eisai

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Eisai

    • Figure Sales and Growth Rate Analysis of Eisai

    • Figure Revenue and Market Share Analysis of Eisai

    • Table Product and Service Introduction of Eisai

    • Table Company Profile and Development Status of Astellas

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Astellas

    • Figure Sales and Growth Rate Analysis of Astellas

    • Figure Revenue and Market Share Analysis of Astellas

    • Table Product and Service Introduction of Astellas

    • Table Company Profile and Development Status of Eli Lilly

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Eli Lilly

    • Figure Sales and Growth Rate Analysis of Eli Lilly

    • Figure Revenue and Market Share Analysis of Eli Lilly

    • Table Product and Service Introduction of Eli Lilly

    • Table Company Profile and Development Status of Boehringer Ingelheim

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Boehringer Ingelheim

    • Figure Sales and Growth Rate Analysis of Boehringer Ingelheim

    • Figure Revenue and Market Share Analysis of Boehringer Ingelheim

    • Table Product and Service Introduction of Boehringer Ingelheim

    • Table Company Profile and Development Status of Actavis

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Actavis

    • Figure Sales and Growth Rate Analysis of Actavis

    • Figure Revenue and Market Share Analysis of Actavis

    • Table Product and Service Introduction of Actavis

    • Table Company Profile and Development Status of Covis

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Covis

    • Figure Sales and Growth Rate Analysis of Covis

    • Figure Revenue and Market Share Analysis of Covis

    • Table Product and Service Introduction of Covis

    • Table Company Profile and Development Status of Desitin Arzneimittel

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Desitin Arzneimittel

    • Figure Sales and Growth Rate Analysis of Desitin Arzneimittel

    • Figure Revenue and Market Share Analysis of Desitin Arzneimittel

    • Table Product and Service Introduction of Desitin Arzneimittel

    • Table Company Profile and Development Status of Endo International

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Endo International

    • Figure Sales and Growth Rate Analysis of Endo International

    • Figure Revenue and Market Share Analysis of Endo International

    • Table Product and Service Introduction of Endo International

    • Table Company Profile and Development Status of Bayer

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Bayer

    • Figure Sales and Growth Rate Analysis of Bayer

    • Figure Revenue and Market Share Analysis of Bayer

    • Table Product and Service Introduction of Bayer

    • Table Company Profile and Development Status of Active Biotech

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Active Biotech

    • Figure Sales and Growth Rate Analysis of Active Biotech

    • Figure Revenue and Market Share Analysis of Active Biotech

    • Table Product and Service Introduction of Active Biotech

    • Table Company Profile and Development Status of UCB

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of UCB

    • Figure Sales and Growth Rate Analysis of UCB

    • Figure Revenue and Market Share Analysis of UCB

    • Table Product and Service Introduction of UCB

    • Table Company Profile and Development Status of F Hoffmann-La Roche

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of F Hoffmann-La Roche

    • Figure Sales and Growth Rate Analysis of F Hoffmann-La Roche

    • Figure Revenue and Market Share Analysis of F Hoffmann-La Roche

    • Table Product and Service Introduction of F Hoffmann-La Roche

    • Table Company Profile and Development Status of Novartis

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Novartis

    • Figure Sales and Growth Rate Analysis of Novartis

    • Figure Revenue and Market Share Analysis of Novartis

    • Table Product and Service Introduction of Novartis

    • Table Company Profile and Development Status of Archer Pharmaceuticals

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Archer Pharmaceuticals

    • Figure Sales and Growth Rate Analysis of Archer Pharmaceuticals

    • Figure Revenue and Market Share Analysis of Archer Pharmaceuticals

    • Table Product and Service Introduction of Archer Pharmaceuticals

    • Table Company Profile and Development Status of Akorn

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Akorn

    • Figure Sales and Growth Rate Analysis of Akorn

    • Figure Revenue and Market Share Analysis of Akorn

    • Table Product and Service Introduction of Akorn

    • Table Company Profile and Development Status of Acorda Therapeutics

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Acorda Therapeutics

    • Figure Sales and Growth Rate Analysis of Acorda Therapeutics

    • Figure Revenue and Market Share Analysis of Acorda Therapeutics

    • Table Product and Service Introduction of Acorda Therapeutics

    • Table Company Profile and Development Status of AB Science

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of AB Science

    • Figure Sales and Growth Rate Analysis of AB Science

    • Figure Revenue and Market Share Analysis of AB Science

    • Table Product and Service Introduction of AB Science

    • Table Company Profile and Development Status of Merck Serono

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Merck Serono

    • Figure Sales and Growth Rate Analysis of Merck Serono

    • Figure Revenue and Market Share Analysis of Merck Serono

    • Table Product and Service Introduction of Merck Serono

    • Table Company Profile and Development Status of Adamas Pharmaceuticals

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Adamas Pharmaceuticals

    • Figure Sales and Growth Rate Analysis of Adamas Pharmaceuticals

    • Figure Revenue and Market Share Analysis of Adamas Pharmaceuticals

    • Table Product and Service Introduction of Adamas Pharmaceuticals

    • Table Company Profile and Development Status of Pfizer

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Pfizer

    • Figure Sales and Growth Rate Analysis of Pfizer

    • Figure Revenue and Market Share Analysis of Pfizer

    • Table Product and Service Introduction of Pfizer

    • Table Company Profile and Development Status of Teva Pharmaceutical Industries

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Teva Pharmaceutical Industries

    • Figure Sales and Growth Rate Analysis of Teva Pharmaceutical Industries

    • Figure Revenue and Market Share Analysis of Teva Pharmaceutical Industries

    • Table Product and Service Introduction of Teva Pharmaceutical Industries

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US